Product logins

Find logins to all Clarivate products below.


Dr Dilpreet Singh MD Ortho

Partner & Head JAPAC Consulting, Clarivate Consulting Services

Dr. Dilpreet Singh, is an experienced life sciences consultant with over 20 years in pharma & biotech. A surgeon turned management consultant turned entrepreneur and back to consulting, he has breadth of experience across the pharma & life sciences segments including operations & strategy execution.

Dilpreet was a Sr. Principal at L.E.K. Consulting and IQVIA (earlier IMS Health), leading the consulting practice across the SEA and APAC region. He has been a trusted advisor to clients across Market access & Go-to-market strategies, product and portfolio lifecycle management from R&D investments to licensing or launch, along with corporate strategies such as M&A, divestment and partnerships. He also has industry experience, most recently at Cerecin, being the COO of the neuro focused biotech with P3 asset in Alzheimer’s Disease and also at Johnson & Johnson earlier.

He has also been a speaker at industry leading events (eg APACMed, ESMO Asia etc), with published thought leadership across new and emerging technologies, and commercial models in biopharma and medical devices space

Dilpreet is passionate about technology in life sciences and founded Juvoxa, a health-tech patient-centric care platform to drive evidence driven outcomes in specialty care. He is actively involved in startup ecosystem in the region, and is an active investor, mentor and advisor to some promising early-stage startups in the region as well.

Dilpreet holds an MBA from the Indian School of Business, Hyderabad and Masters in Surgery (Orthopedics) from All India Institute of Medical Sciences, Delhi

Related resources

AI 驱动数据整理:原发性震颤流行病学迎来新方法 AI 驱动数据整理:原发性震颤流行病学迎来新方法
Blog November 17, 2025
AI 驱动数据整理:原发性震颤流行病学迎来新方法
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇 药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
Blog October 13, 2025
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
六家公司为“不可成药”靶点实现精准干预 六家公司为“不可成药”靶点实现精准干预
Blog October 7, 2025
六家公司为“不可成药”靶点实现精准干预
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐 GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐
Blog October 3, 2025
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐